시장보고서
상품코드
1470722

OTC 흉터 치료 시장 : 제품 유형별, 최종사용자별, 지역별 - 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2031년)

OTC Scar Treatment Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

발행일: | 리서치사: Persistence Market Research | 페이지 정보: 영문 250 Pages | 배송안내 : 2-5일 (영업일 기준)

    
    
    


■ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

OTC 흉터 치료 시장 조사 보고서는 시장 역학, 성장요인, 과제, 신규 동향에 관한 인사이트와 분석을 제공하고 있습니다. 2024-2031년의 시장 궤적에 관한 데이터와 통계를 포함하여 OTC 흉터 치료 시장의 현황과 전망에 관한 귀중한 인사이트를 제공합니다.

세계의 OTC 흉터 치료 시장은 2024년 88억 2,000만 달러에서 2031년에는 120억 달러에 달하며, CAGR 3.8%로 성장할 것으로 예측됩니다.

주요 인사이트

  • 추정 시장 규모(2024년) : 88억 2,000만 달러
  • 예측 시장 규모(2031년) 120억 달러
  • 세계 시장 성장률(CAGR 2024-2031년) : 3.8%

OTC 흉터 치료 시장 - 리포트 범위 :

OTC 흉터 치료 제품은 처방전 없이 흉터를 관리하고 개선할 수 있는 솔루션을 원하는 개인을 대상으로 합니다. 이러한 제품에는 상처, 수술, 여드름 및 기타 피부 손상으로 인한 흉터를 눈에 띄지 않게 하기 위해 고안된 국소용 크림, 젤, 실리콘 시트 및 기타 제형들이 포함됩니다. 이 보고서는 피부 관리에 대한 인식 증가, 피부 질환 유병률 증가, 비침습적이고 비용 효율적인 흉터 관리 솔루션에 대한 수요 증가 등 OTC 흉터 치료 제품에 대한 수요를 지원하는 주요 요인을 설명합니다. 또한 제형 기술의 발전, 성분의 혁신, 제품 접근성 향상 등으로 인해 소비자가 선택할 수 있는 OTC 흉터 치료제의 선택의 폭이 넓어짐에 따라 시장 성장에 기여하고 있습니다.

시장 성장의 촉진요인:

시장의 성장은 몇 가지 요인에 의해 이루어지고 있습니다. 먼저, 피부 관리와 미용에 대한 소비자의 인식이 높아지면서 일상적인 피부 관리의 일환으로 OTC 흉터 치료 제품에 대한 수요가 증가하고 있습니다. 또한 여드름, 습진, 피부염과 같은 피부 질환의 유병률 증가, 수술 및 부상 증가로 인해 흉터 관리 솔루션에 대한 수요가 증가하고 있습니다. 또한 약국, 약국 및 온라인 소매 채널에서 OTC 흉터 치료 제품을 이용할 수 있게 되면서 소비자의 제품 접근성과 편의성이 향상되어 시장 성장을 더욱 촉진하고 있습니다.

시장 성장 억제요인 :

전망은 밝지만, OTC 흉터 치료 시장은 일정한 문제에 직면해 있습니다. 제한적인 효과와 흉터 유형 및 개인에 따라 치료 결과에 차이가 있다는 점은 소비자 만족도와 브랜드 충성도에 영향을 미치고 구매 결정에 영향을 미칠 수 있습니다. 또한 처방약, 미용성형, 자연요법 등 대체 흉터 치료 옵션과의 경쟁이 치열해 시장 침투와 제품 차별화에 어려움을 겪을 수 있습니다. 또한 규제 제약, 안전성 우려, OTC 흉터치료제 성분에 대한 논란 등은 시장 성장과 기술 혁신을 저해하고 제품 개발 및 마케팅 전략에 영향을 미칠 수 있습니다.

시장 기회 :

OTC 흉터 치료제 시장에는 기술 혁신과 제품 개발의 큰 기회가 있습니다. 제조업체들은 실리콘, 비타민 E, 양파 추출물 등 흉터 축소 및 피부 재생에 효과가 있는 것으로 임상적으로 입증된 성분을 함유한 고급 제제 개발에 집중할 수 있습니다. 또한 흉터 유형에 특화된 제품이나 맞춤형 치료 요법 등 맞춤형 및 개인화 옵션을 통해 OTC 흉터 치료 브랜드는 다양한 소비자의 니즈와 선호도를 충족시킬 수 있습니다. 또한 피부과 전문의, 스킨케어 전문가, 인플루언서와의 전략적 파트너십을 통해 시장 침투와 브랜드 신뢰도를 높이고 소비자 신뢰와 충성도를 높일 수 있습니다.

이 보고서에서 다룬 주요 질문

  • 2024-2031년 OTC 흉터 치료 시장의 예상 CAGR은?
  • OTC 흉터 치료 시장의 성장을 가속하는 주요 요인은 무엇인가?
  • OTC 흉터 치료 시장에서 가장 큰 시장 점유율을 차지하는 제품 유형은?
  • OTC 흉터치료제 세계 시장의 주요 기업은?
  • OTC 흉터 치료 시장에서 경쟁력을 유지하기 위해 주요 기업은 어떤 전략을 채택하고 있는가?

경쟁 환경 및 사업 전략:

OTC 흉터 치료제 시장의 주요 기업으로는 Johnson &Johnson Services, Inc. Labs, LLC 등이 있습니다. 이들 기업은 시장 차별화와 경쟁 우위를 확보하기 위해 제품 혁신, 브랜드 구축, 마케팅 전략에 집중하고 있습니다. 예를 들어 Johnson &Johnson Services, Inc.는 Neosporin과 Band-Aid 브랜드로 다양한 OTC 흉터 치료 제품을 제공하고 있으며, Mederma, Inc. 전문으로 하고 있습니다. 또한 각 업체들은 임상 연구, 소비자 교육, 전문가 추천에 투자하여 제품의 효능과 안전성을 검증함으로써 소비자의 신뢰와 브랜드 충성도를 높이고 있습니다.

주요 기업 개요 :

  • Johnson & Johnson Services, Inc.
  • Mederma, Inc.(Merz Pharmaceuticals GmbH)
  • Smith & Nephew plc
  • Alliance Pharma plc
  • Scarguard Labs, LLC

OTC 흉터 치료 시장의 세분화 :

제품별

  • 국소용 흉터 제품
  • 크림/연고
  • 오일
  • 시트
  • 기타

용도별

  • 위축성 반흔
  • 비후성 반흔과 켈로이드
  • 구축
  • 화상
  • 튼살

유통 채널별

  • 병원 약국
  • 소매 약국
  • E-Commerce

지역별

  • 북미
  • 라틴아메리카
  • 유럽
  • 남아시아
  • 동아시아
  • 오세아니아
  • 중동 및 아프리카

목차

제1장 주요 요약

제2장 시장 개요

  • 시장 범위/ 분류
  • 시장의 정의/ 범위/ 제한
  • 포함 사항·제외 사항

제3장 주요 시장 동향

  • 시장에 영향을 미치는 주요 동향
  • 제품 혁신/개발 동향

제4장 주요 성공요인

  • 주요 제조업체에 의한 프로모션 전략
  • 주요 규제
  • 밸류체인 분석
  • PESTEL 분석
  • Porter의 산업 분석

제5장 시장 배경

  • 거시경제 요인
  • 예측 요인 - 관련성과 영향
  • 시장 역학

제6장 COVID-19 위기 분석

  • COVID-19로 영향 분석
    • 제품별
    • 용도별
    • 유통 채널별
    • 국가별
  • 2023년 시장 시나리오

제7장 세계의 OTC 흉터 치료 시장 - 가격 분석

  • 제품별 지역 가격 분석
  • 가격의 내역
    • 제조업체 레벨의 가격 설정
    • 유통업체 레벨의 가격 설정
  • 세계 평균 가격 분석 벤치마크
  • 가격결정 전제

제8장 세계의 OTC 흉터 치료 시장의 수요 분석(2012-2023년)과 예측(2024-2031년)

  • 과거 시장 규모 분석(2012-2023년)
  • 현재 및 향후 시장 규모 예측(2024-2031년)
    • 전년대비 성장 동향 분석
    • 절대액의 기회 분석

제9장 세계의 OTC 흉터 치료 시장 분석(2012-2023년)과 예측(2024-2031년) : 제품별

  • 서론/주요 조사 결과
  • 과거 시장 규모 분석(2012-2023년) : 제품별
  • 현재 및 향후 시장 규모 예측(2024-2031년) : 제품별
    • 국소용 흉터 치료 제품
    • 기타
  • 제품별 시장의 매력 분석

제10장 세계의 OTC 흉터 치료 시장 분석(2012-2023년)과 예측(2024-2031년) : 용도별

  • 서론/주요 조사 결과
  • 과거 시장 규모 분석(2012-2023년) : 용도별
  • 현재 및 향후 시장 규모 예측(2024-2031년) : 용도별
    • 위축성 반흔
    • 비후성 반흔과 켈로이드
    • 구축
    • 화상
    • 튼살
  • 용도별 시장의 매력 분석

제11장 세계의 OTC 흉터 치료 시장 분석(2012-2023년)과 예측(2024-2031년) : 유통 채널별

  • 서론/주요 조사 결과
  • 과거 시장 규모 분석(2012-2023년) : 유통 채널별
  • 현재 및 향후 시장 규모 예측(2024-2031년) : 유통 채널별
    • 병원 약국
    • 소매 약국
    • E-Commerce
  • 유통 채널별 시장의 매력 분석

제12장 세계의 OTC 흉터 치료 시장 분석(2012-2023년)과 예측(2024-2031년) : 지역별

  • 서론/주요 조사 결과
  • 과거 시장 규모 분석(2012-2023년) : 지역별
  • 현재 및 향후 시장 규모 예측(2024-2031년) : 지역별
    • 북미
    • 라틴아메리카
    • 유럽
    • 동아시아
    • 남아시아
    • 오세아니아
    • 중동 및 아프리카
  • 지역별 시장의 매력 분석

제13장 북미의 OTC 흉터 치료 시장 분석(2012-2023년)과 예측(2024-2031년)

제14장 라틴아메리카의 OTC 흉터 치료 시장 분석(2012-2023년)과 예측(2024-2031년)

제15장 유럽의 OTC 흉터 치료 시장 분석(2012-2023년)과 예측(2024-2031년)

제16장 동아시아의 OTC 흉터 치료 시장 분석(2012-2023년)과 예측(2024-2031년)

제17장 남아시아의 OTC 흉터 치료 시장 분석(2012-2023년)과 예측(2024-2031년)

제18장 오세아니아의 OTC 흉터 치료 시장 분석(2012-2023년)과 예측(2024-2031년)

  • 서론
  • 과거 시장 규모 추이 분석(2012-2023년) : 시장 분류별
  • 현재 및 향후 시장 규모 분석과 예측(2024-2031년) : 시장 분류별
    • 국가별
    • 제품별
    • 용도별
    • 유통 채널별
  • 시장의 매력 분석
  • 주요 시장 참여 기업 - 강도 매핑
  • 촉진요인과 억제요인 - 영향 분석
  • 국가 레벨의 분석과 예측

제19장 중동 및 아프리카의 OTC 흉터 치료 시장 분석(2012-2023년)과 예측(2024-2031년)

제20장 시장 구조 분석

  • 기업 계층별 시장 분석
  • 시장 집중
  • 주요 기업의 시장 점유율 분석(%)
  • 시장 입지 분석

제21장 경쟁 분석

  • 경쟁 대시보드
  • 경쟁 벤치마킹
  • 경쟁의 상세
    • Smith &Nephew PLC
    • Merz Inc.
    • Enaltus LLC
    • Occulus Innovative Sciences Inc.
    • CCA Industries Inc.
    • Cynosure Inc
    • Avita Medical Limited
    • Lumenis
    • Syneron Medical Ltd.
    • Nutramarks Inc.
    • Molnlycke Health Care
    • Pacific World Corporation
    • Valeant Pharmaceuticals International Inc.
    • Shanghai Fosun Pharmaceuticals Ltd.(AC. Alma Lasers)
    • SkinCeuticals
    • A. Menarini Singapore Pte. Ltd.

제22장 전제와 두자어

제23장 조사 방법

KSA 24.05.16

The OTC Scar Treatment Market report by Persistence Market Research provides an insightful analysis of market dynamics, growth factors, challenges, and emerging trends. It encompasses data and statistics on the market's trajectory from 2024 to 2031, offering valuable insights into the current state and future prospects of the OTC Scar Treatment Market.

The global OTC scar treatment market is projected to grow at a compound annual growth rate (CAGR) of 3.8% from USD 8.82 billion in 2024 to USD 12 billion by 2031.

Key Insights:

  • Estimated Market Size (2024): USD 8.82 Billion
  • Projected Market Size (2031): USD 12 Billion
  • Global Market Growth Rate (CAGR 2024 to 2031): 3.8%

OTC Scar Treatment Market - Report Scope:

Over-the-counter (OTC) scar treatment products cater to individuals seeking solutions for scar management and improvement without requiring a prescription. These products include topical creams, gels, silicone sheets, and other formulations designed to reduce the appearance of scars resulting from wounds, surgeries, acne, and other skin injuries. The report outlines key drivers behind the demand for OTC scar treatment products, including increasing awareness of skincare, rising prevalence of skin conditions, and growing demand for non-invasive and cost-effective scar management solutions. Moreover, advancements in formulation technologies, ingredient innovation, and product accessibility drive market growth by expanding the range of OTC scar treatment options available to consumers.

Market Growth Drivers:

The market's growth is driven by several factors. Firstly, rising consumer awareness of skincare and aesthetics drives demand for OTC scar treatment products as part of daily skincare routines. Additionally, the growing prevalence of skin conditions such as acne, eczema, and dermatitis, coupled with an increase in surgical procedures and injuries, fuels demand for scar management solutions. Moreover, the availability of OTC scar treatment products in pharmacies, drugstores, and online retail channels enhances product accessibility and convenience for consumers, further boosting market growth.

Market Restraints:

Despite the positive outlook, the OTC Scar Treatment Market faces certain challenges. Limited efficacy and variability in treatment outcomes across different scar types and individuals may impact consumer satisfaction and brand loyalty, influencing purchasing decisions. Moreover, intense competition from alternative scar management options, including prescription medications, cosmetic procedures, and natural remedies, may pose challenges to market penetration and product differentiation. Additionally, regulatory constraints, safety concerns, and ingredient controversies in OTC scar treatment formulations may hinder market growth and innovation, impacting product development and marketing strategies.

Market Opportunities:

The OTC Scar Treatment Market offers significant opportunities for innovation and product development. Manufacturers can focus on developing advanced formulations with clinically proven ingredients, such as silicone, vitamin E, and onion extract, known for their efficacy in scar reduction and skin regeneration. Moreover, customization and personalization options, including scar type-specific products and tailored treatment regimens, enable OTC scar treatment brands to address diverse consumer needs and preferences. Furthermore, strategic partnerships with dermatologists, skincare professionals, and influencers facilitate market penetration and brand credibility, driving consumer trust and loyalty.

Key Questions Addressed in the Report:

  • What is the Expected CAGR of the OTC Scar Treatment Market from 2024 to 2031?
  • What are the Key Factors Driving the Growth of the OTC Scar Treatment Market?
  • Which Product Type Holds the Largest Market Share in the OTC Scar Treatment Market?
  • Who are the Key Players in the Global OTC Scar Treatment Market?
  • What Strategies are Adopted by Leading Companies to Stay Competitive in the OTC Scar Treatment Market?

Competitive Landscape and Business Strategies:

Key players in the OTC Scar Treatment Market include Johnson & Johnson Services, Inc., Mederma, Inc. (Merz Pharmaceuticals GmbH), Smith & Nephew plc, Alliance Pharma plc, and Scarguard Labs, LLC. These companies focus on product innovation, brand building, and marketing strategies to differentiate themselves in the market and gain a competitive edge. For instance, Johnson & Johnson Services, Inc. offers a range of OTC scar treatment products under the Neosporin and Band-Aid brands, while Mederma, Inc. specializes in scar gels, creams, and ointments with proprietary formulations for scar reduction and skin hydration. Market players also invest in clinical research, consumer education, and professional endorsements to validate product efficacy and safety claims, driving consumer confidence and brand loyalty.

Key Companies Profiled:

  • Johnson & Johnson Services, Inc.
  • Mederma, Inc. (Merz Pharmaceuticals GmbH)
  • Smith & Nephew plc
  • Alliance Pharma plc
  • Scarguard Labs, LLC

OTC Scar Treatment Market Segmentation:

By Product:

  • Topical Scar Products
  • Gels
  • Creams/Ointments
  • Oils
  • Sheets
  • Others

By Application:

  • Atrophic Scars
  • Hypertrophic Scars and Keloids
  • Contractures
  • Burns
  • Stretch Marks

By Distribution Channel:

  • Hospitals Pharmacies
  • Retail Pharmacies
  • E-Commerce

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Promotional Strategies, By Key Manufacturers
  • 4.2. Key Regulations
  • 4.3. Value Chain Analysis
  • 4.4. PESTEL Analysis
  • 4.5. Porter's Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Expenditure Outlook
    • 5.1.3. Global Scar Treatment Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Increasing Number of Road Accidents and Injuries
    • 5.2.2. Growing Adoption of Cosmetic Products
    • 5.2.3. Rising Demand for Non-Invasive Scar Treatment Solutions
    • 5.2.4. Availability and Accessibility of Products
    • 5.2.5. Rising Prevalence of Dermatological Diseases
    • 5.2.6. Increasing Disposable Income of Consumers
    • 5.2.7. Introduction of Natural and Organic Products
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Product
    • 6.1.2. By Application
    • 6.1.3. By Distribution Channel
    • 6.1.4. By Country
  • 6.2. 2023 Market Scenario

7. Global OTC Scar Treatment Market - Pricing Analysis

  • 7.1. Regional Pricing Analysis By Product
  • 7.2. Pricing Break-up
    • 7.2.1. Manufacturer Level Pricing
    • 7.2.2. Distributor Level Pricing
  • 7.3. Global Average Pricing Analysis Benchmark
  • 7.4. Pricing Assumptions

8. Global OTC Scar Treatment Market Demand (in Value or Size in US$ Mn) Analysis 2012-2023 and Forecast, 2024-2031

  • 8.1. Historical Market Value (US$ Mn) Analysis, 2012-2023
  • 8.2. Current and Future Market Value (US$ Mn) Projections, 2024-2031
    • 8.2.1. Y-o-Y Growth Trend Analysis
    • 8.2.2. Absolute $ Opportunity Analysis

9. Global OTC Scar Treatment Market Analysis 2012-2023 and Forecast 2024-2031, By Product

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis By Product, 2012 - 2023
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2024-2031
    • 9.3.1. Topical Scar Products
      • 9.3.1.1. Gels
      • 9.3.1.2. Creams/Ointments
      • 9.3.1.3. Oils
      • 9.3.1.4. Sheets
    • 9.3.2. Others
  • 9.4. Market Attractiveness Analysis By Product

10. Global OTC Scar Treatment Market Analysis 2012-2023 and Forecast 2024-2031, By Application

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis By Application, 2012 - 2023
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2024-2031
    • 10.3.1. Atrophic Scars
    • 10.3.2. Hypertrophic Scars and Keloids
    • 10.3.3. Contractures
    • 10.3.4. Burns
    • 10.3.5. Stretch Marks
  • 10.4. Market Attractiveness Analysis By Application

11. Global OTC Scar Treatment Market Analysis 2012-2023 and Forecast 2024-2031, By Distribution Channel

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2012 - 2023
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2024-2031
    • 11.3.1. Hospitals Pharmacies
    • 11.3.2. Retail Pharmacies
    • 11.3.3. E-Commerce
  • 11.4. Market Attractiveness Analysis By Distribution Channel

12. Global OTC Scar Treatment Market Analysis 2012-2023 and Forecast 2024-2031, By Region

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Mn) Analysis By Region, 2012-2023
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2024-2031
    • 12.3.1. North America
    • 12.3.2. Latin America
    • 12.3.3. Europe
    • 12.3.4. East Asia
    • 12.3.5. South Asia
    • 12.3.6. Oceania
    • 12.3.7. Middle East and Africa
  • 12.4. Market Attractiveness Analysis By Region

13. North America OTC Scar Treatment Market Analysis 2012-2023 and Forecast 2024-2031

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2012-2023
  • 13.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2024-2031
    • 13.3.1. By Country
      • 13.3.1.1. U.S.
      • 13.3.1.2. Canada
    • 13.3.2. By Product
    • 13.3.3. By Application
    • 13.3.4. By Distribution Channel
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Product
    • 13.4.3. By Application
    • 13.4.4. By Distribution Channel
  • 13.5. Market Trends
  • 13.6. Key Market Participants - Intensity Mapping
  • 13.7. Drivers and Restraints - Impact Analysis
  • 13.8. Country Level Analysis & Forecast
    • 13.8.1. U.S. OTC Scar Treatment Market Analysis
      • 13.8.1.1. Introduction
      • 13.8.1.2. Market Analysis and Forecast By Market Taxonomy
        • 13.8.1.2.1. By Country
        • 13.8.1.2.2. By Product
        • 13.8.1.2.3. By Application
        • 13.8.1.2.4. By Distribution Channel
    • 13.8.2. Canada OTC Scar Treatment Market Analysis
      • 13.8.2.1. Introduction
      • 13.8.2.2. Market Analysis and Forecast By Market Taxonomy
        • 13.8.2.2.1. By Country
        • 13.8.2.2.2. By Product
        • 13.8.2.2.3. By Application
        • 13.8.2.2.4. By Distribution Channel

14. Latin America OTC Scar Treatment Market Analysis 2012-2023 and Forecast 2024-2031

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2012-2023
  • 14.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2024-2031
    • 14.3.1. By Country
      • 14.3.1.1. Mexico
      • 14.3.1.2. Brazil
      • 14.3.1.3. Argentina
      • 14.3.1.4. Rest of Latin America
        • 14.3.1.4.1. By Product
        • 14.3.1.4.2. By Application
        • 14.3.1.4.3. By Distribution Channel
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By Application
    • 14.4.4. By Distribution Channel
  • 14.5. Market Trends
  • 14.6. Key Market Participants - Intensity Mapping
  • 14.7. Drivers and Restraints - Impact Analysis
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. Mexico OTC Scar Treatment Market Analysis
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast By Market Taxonomy
        • 14.8.1.2.1. By Product
        • 14.8.1.2.2. By Application
        • 14.8.1.2.3. By Distribution Channel
    • 14.8.2. Brazil OTC Scar Treatment Market Analysis
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast By Market Taxonomy
        • 14.8.2.2.1. By Product
        • 14.8.2.2.2. By Application
        • 14.8.2.2.3. By Distribution Channel
    • 14.8.3. Argentina OTC Scar Treatment Market Analysis
      • 14.8.3.1. Introduction
      • 14.8.3.2. Market Analysis and Forecast By Market Taxonomy
        • 14.8.3.2.1. By Product
        • 14.8.3.2.2. By Application
        • 14.8.3.2.3. By Distribution Channel

15. Europe OTC Scar Treatment Market Analysis 2012-2023 and Forecast 2024-2031

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2012-2023
  • 15.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2024-2031
    • 15.3.1. By Country
      • 15.3.1.1. Germany
      • 15.3.1.2. Italy
      • 15.3.1.3. France
      • 15.3.1.4. U.K.
      • 15.3.1.5. Spain
      • 15.3.1.6. BENELUX
      • 15.3.1.7. Russia
      • 15.3.1.8. Rest of Europe
    • 15.3.2. By Product
    • 15.3.3. By Application
    • 15.3.4. By Distribution Channel
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By Application
    • 15.4.4. By Distribution Channel
  • 15.5. Market Trends
  • 15.6. Key Market Participants - Intensity Mapping
  • 15.7. Drivers and Restraints - Impact Analysis
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. Germany OTC Scar Treatment Market Analysis
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast By Market Taxonomy
        • 15.8.1.2.1. By Product
        • 15.8.1.2.2. By Application
        • 15.8.1.2.3. By Distribution Channel
    • 15.8.2. Italy OTC Scar Treatment Market Analysis
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast By Market Taxonomy
        • 15.8.2.2.1. By Product
        • 15.8.2.2.2. By Application
        • 15.8.2.2.3. By Distribution Channel
    • 15.8.3. France OTC Scar Treatment Market Analysis
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast By Market Taxonomy
        • 15.8.3.2.1. By Product
        • 15.8.3.2.2. By Application
        • 15.8.3.2.3. By Distribution Channel
    • 15.8.4. U.K. OTC Scar Treatment Market Analysis
      • 15.8.4.1. Introduction
      • 15.8.4.2. Market Analysis and Forecast By Market Taxonomy
        • 15.8.4.2.1. By Product
        • 15.8.4.2.2. By Application
        • 15.8.4.2.3. By Distribution Channel
    • 15.8.5. Spain OTC Scar Treatment Market Analysis
      • 15.8.5.1. Introduction
      • 15.8.5.2. Market Analysis and Forecast By Market Taxonomy
        • 15.8.5.2.1. By Product
        • 15.8.5.2.2. By Application
        • 15.8.5.2.3. By Distribution Channel
    • 15.8.6. BENELUX OTC Scar Treatment Market Analysis
      • 15.8.6.1. Introduction
      • 15.8.6.2. Market Analysis and Forecast By Market Taxonomy
        • 15.8.6.2.1. By Product
        • 15.8.6.2.2. By Application
        • 15.8.6.2.3. By Distribution Channel
    • 15.8.7. Russia OTC Scar Treatment Market Analysis
      • 15.8.7.1. Introduction
      • 15.8.7.2. Market Analysis and Forecast By Market Taxonomy
        • 15.8.7.2.1. By Product
        • 15.8.7.2.2. By Application
        • 15.8.7.2.3. By Distribution Channel

16. East Asia OTC Scar Treatment Market Analysis 2012-2023 and Forecast 2024-2031

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2012-2023
  • 16.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2024-2031
    • 16.3.1. By Country
      • 16.3.1.1. China
      • 16.3.1.2. Japan
      • 16.3.1.3. South Korea
    • 16.3.2. By Product
    • 16.3.3. By Application
    • 16.3.4. By Distribution Channel
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Application
    • 16.4.4. By Distribution Channel
  • 16.5. Market Trends
  • 16.6. Key Market Participants - Intensity Mapping
  • 16.7. Drivers and Restraints - Impact Analysis
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. China OTC Scar Treatment Market Analysis
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast By Market Taxonomy
        • 16.8.1.2.1. By Product
        • 16.8.1.2.2. By Application
        • 16.8.1.2.3. By Distribution Channel
    • 16.8.2. Japan OTC Scar Treatment Market Analysis
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast By Market Taxonomy
        • 16.8.2.2.1. By Product
        • 16.8.2.2.2. By Application
        • 16.8.2.2.3. By Distribution Channel
    • 16.8.3. South Korea OTC Scar Treatment Market Analysis
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast By Market Taxonomy
        • 16.8.3.2.1. By Product
        • 16.8.3.2.2. By Application
        • 16.8.3.2.3. By Distribution Channel

17. South Asia OTC Scar Treatment Market Analysis 2012-2023 and Forecast 2024-2031

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2012-2023
  • 17.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2024-2031
    • 17.3.1. By Country
      • 17.3.1.1. India
      • 17.3.1.2. Indonesia
      • 17.3.1.3. Malaysia
      • 17.3.1.4. Thailand
      • 17.3.1.5. Rest of South Asia
    • 17.3.2. By Product
    • 17.3.3. By Application
    • 17.3.4. By Distribution Channel
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By Application
    • 17.4.4. By Distribution Channel
  • 17.5. Market Trends
  • 17.6. Key Market Participants - Intensity Mapping
  • 17.7. Drivers and Restraints - Impact Analysis
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. India OTC Scar Treatment Market Analysis
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast By Market Taxonomy
        • 17.8.1.2.1. By Product
        • 17.8.1.2.2. By Application
        • 17.8.1.2.3. By Distribution Channel
    • 17.8.2. Indonesia OTC Scar Treatment Market Analysis
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast By Market Taxonomy
        • 17.8.2.2.1. By Product
        • 17.8.2.2.2. By Application
        • 17.8.2.2.3. By Distribution Channel
    • 17.8.3. Malaysia OTC Scar Treatment Market Analysis
      • 17.8.3.1. Introduction
      • 17.8.3.2. Market Analysis and Forecast By Market Taxonomy
        • 17.8.3.2.1. By Product
        • 17.8.3.2.2. By Application
        • 17.8.3.2.3. By Distribution Channel
    • 17.8.4. Thailand OTC Scar Treatment Market Analysis
      • 17.8.4.1. Introduction
      • 17.8.4.2. Market Analysis and Forecast By Market Taxonomy
        • 17.8.4.2.1. By Product
        • 17.8.4.2.2. By Application
        • 17.8.4.2.3. By Distribution Channel

18. Oceania OTC Scar Treatment Market 2012-2023 and Forecast 2024-2031

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2012-2023
  • 18.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2024-2031
    • 18.3.1. By Country
      • 18.3.1.1. Australia
      • 18.3.1.2. New Zealand
    • 18.3.2. By Product
    • 18.3.3. By Application
    • 18.3.4. By Distribution Channel
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Product
    • 18.4.3. By Application
    • 18.4.4. By Distribution Channel
  • 18.5. Key Market Participants - Intensity Mapping
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Country Level Analysis & Forecast
    • 18.7.1. Australia OTC Scar Treatment Market Analysis
      • 18.7.1.1. Introduction
      • 18.7.1.2. Market Analysis and Forecast By Market Taxonomy
        • 18.7.1.2.1. By Product
        • 18.7.1.2.2. By Application
        • 18.7.1.2.3. By Distribution Channel
    • 18.7.2. New Zealand OTC Scar Treatment Market Analysis
      • 18.7.2.1. Introduction
      • 18.7.2.2. Market Analysis and Forecast By Market Taxonomy
        • 18.7.2.2.1. By Product
        • 18.7.2.2.2. By Application
        • 18.7.2.2.3. By Distribution Channel

19. Middle East and Africa (MEA) OTC Scar Treatment Market Analysis 2012-2023 and Forecast 2024-2031

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2012-2023
  • 19.3. Current and Future Market Size (US$ Mn) Analysis & Forecast By Market Taxonomy, 2024-2031
    • 19.3.1. By Country
      • 19.3.1.1. GCC Countries
      • 19.3.1.2. Turkey
      • 19.3.1.3. South Africa
      • 19.3.1.4. North Africa
      • 19.3.1.5. Rest of Middle East and Africa
    • 19.3.2. By Product
    • 19.3.3. By Application
    • 19.3.4. By Distribution Channel
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Product
    • 19.4.3. By Application
    • 19.4.4. By Distribution Channel
  • 19.5. Market Trends
  • 19.6. Key Market Participants - Intensity Mapping
  • 19.7. Drivers and Restraints - Impact Analysis
  • 19.8. Country Level Analysis & Forecast
    • 19.8.1. GCC Countries OTC Scar Treatment Market Analysis
      • 19.8.1.1. Introduction
      • 19.8.1.2. Market Analysis and Forecast By Market Taxonomy
        • 19.8.1.2.1. By Product
        • 19.8.1.2.2. By Application
        • 19.8.1.2.3. By Distribution Channel
    • 19.8.2. Turkey OTC Scar Treatment Market Analysis
      • 19.8.2.1. Introduction
      • 19.8.2.2. Market Analysis and Forecast By Market Taxonomy
        • 19.8.2.2.1. By Product
        • 19.8.2.2.2. By Application
        • 19.8.2.2.3. By Distribution Channel
    • 19.8.3. South Africa OTC Scar Treatment Market Analysis
      • 19.8.3.1. Introduction
      • 19.8.3.2. Market Analysis and Forecast By Market Taxonomy
        • 19.8.3.2.1. By Product
        • 19.8.3.2.2. By Application
        • 19.8.3.2.3. By Distribution Channel
    • 19.8.4. North Africa OTC Scar Treatment Market Analysis
      • 19.8.4.1. Introduction
      • 19.8.4.2. Market Analysis and Forecast By Market Taxonomy
        • 19.8.4.2.1. By Product
        • 19.8.4.2.2. By Application
        • 19.8.4.2.3. By Distribution Channel

20. Market Structure Analysis

  • 20.1. Market Analysis By Tier of Companies
  • 20.2. Market Concentration
  • 20.3. Market Share Analysis (%) of Top Players
  • 20.4. Market Presence Analysis

21. Competition Analysis

  • 21.1. Competition Dashboard
  • 21.2. Competition Benchmarking
  • 21.3. Competition Deep Dive
    • 21.3.1. Smith & Nephew PLC
      • 21.3.1.1. Overview
      • 21.3.1.2. Product Portfolio
      • 21.3.1.3. Sales Footprint
      • 21.3.1.4. Key Financials
      • 21.3.1.5. SWOT Analysis
      • 21.3.1.6. Strategic Overview
    • 21.3.2. Merz Inc.
      • 21.3.2.1. Overview
      • 21.3.2.2. Product Portfolio
      • 21.3.2.3. Sales Footprint
      • 21.3.2.4. Key Financials
      • 21.3.2.5. SWOT Analysis
      • 21.3.2.6. Strategic Overview
    • 21.3.3. Enaltus LLC
      • 21.3.3.1. Overview
      • 21.3.3.2. Product Portfolio
      • 21.3.3.3. Sales Footprint
      • 21.3.3.4. Key Financials
      • 21.3.3.5. SWOT Analysis
      • 21.3.3.6. Strategic Overview
    • 21.3.4. Occulus Innovative Sciences Inc.
      • 21.3.4.1. Overview
      • 21.3.4.2. Product Portfolio
      • 21.3.4.3. Sales Footprint
      • 21.3.4.4. Key Financials
      • 21.3.4.5. SWOT Analysis
      • 21.3.4.6. Strategic Overview
    • 21.3.5. CCA Industries Inc.
      • 21.3.5.1. Overview
      • 21.3.5.2. Product Portfolio
      • 21.3.5.3. Sales Footprint
      • 21.3.5.4. Key Financials
      • 21.3.5.5. SWOT Analysis
      • 21.3.5.6. Strategic Overview
    • 21.3.6. Cynosure Inc
      • 21.3.6.1. Overview
      • 21.3.6.2. Product Portfolio
      • 21.3.6.3. Sales Footprint
      • 21.3.6.4. Key Financials
      • 21.3.6.5. SWOT Analysis
      • 21.3.6.6. Strategic Overview
    • 21.3.7. Avita Medical Limited
      • 21.3.7.1. Overview
      • 21.3.7.2. Product Portfolio
      • 21.3.7.3. Sales Footprint
      • 21.3.7.4. Key Financials
      • 21.3.7.5. SWOT Analysis
      • 21.3.7.6. Strategic Overview
    • 21.3.8. Lumenis
      • 21.3.8.1. Overview
      • 21.3.8.2. Product Portfolio
      • 21.3.8.3. Sales Footprint
      • 21.3.8.4. Key Financials
      • 21.3.8.5. SWOT Analysis
      • 21.3.8.6. Strategic Overview
    • 21.3.9. Syneron Medical Ltd.
      • 21.3.9.1. Overview
      • 21.3.9.2. Product Portfolio
      • 21.3.9.3. Sales Footprint
      • 21.3.9.4. Key Financials
      • 21.3.9.5. SWOT Analysis
      • 21.3.9.6. Strategic Overview
    • 21.3.10. Nutramarks Inc.
      • 21.3.10.1. Overview
      • 21.3.10.2. Product Portfolio
      • 21.3.10.3. Sales Footprint
      • 21.3.10.4. Key Financials
      • 21.3.10.5. SWOT Analysis
      • 21.3.10.6. Strategic Overview
    • 21.3.11. Molnlycke Health Care
      • 21.3.11.1. Overview
      • 21.3.11.2. Product Portfolio
      • 21.3.11.3. Sales Footprint
      • 21.3.11.4. Key Financials
      • 21.3.11.5. SWOT Analysis
      • 21.3.11.6. Strategic Overview
    • 21.3.12. Pacific World Corporation
      • 21.3.12.1. Overview
      • 21.3.12.2. Product Portfolio
      • 21.3.12.3. Sales Footprint
      • 21.3.12.4. Key Financials
      • 21.3.12.5. SWOT Analysis
      • 21.3.12.6. Strategic Overview
    • 21.3.13. Valeant Pharmaceuticals International Inc.
      • 21.3.13.1. Overview
      • 21.3.13.2. Product Portfolio
      • 21.3.13.3. Sales Footprint
      • 21.3.13.4. Key Financials
      • 21.3.13.5. SWOT Analysis
      • 21.3.13.6. Strategic Overview
    • 21.3.14. Shanghai Fosun Pharmaceuticals Ltd. (AC. Alma Lasers)
      • 21.3.14.1. Overview
      • 21.3.14.2. Product Portfolio
      • 21.3.14.3. Sales Footprint
      • 21.3.14.4. Key Financials
      • 21.3.14.5. SWOT Analysis
      • 21.3.14.6. Strategic Overview
    • 21.3.15. SkinCeuticals
      • 21.3.15.1. Overview
      • 21.3.15.2. Product Portfolio
      • 21.3.15.3. Sales Footprint
      • 21.3.15.4. Key Financials
      • 21.3.15.5. SWOT Analysis
      • 21.3.15.6. Strategic Overview
    • 21.3.16. A. Menarini Singapore Pte. Ltd.
      • 21.3.16.1. Overview
      • 21.3.16.2. Product Portfolio
      • 21.3.16.3. Sales Footprint
      • 21.3.16.4. Key Financials
      • 21.3.16.5. SWOT Analysis
      • 21.3.16.6. Strategic Overview

22. Assumptions and Acronyms Used

23. Research Methodology

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제